Decreased brain reward produced by ethanol withdrawal - PubMed (original) (raw)
Comparative Study
Decreased brain reward produced by ethanol withdrawal
G Schulteis et al. Proc Natl Acad Sci U S A. 1995.
Abstract
Abstinence from chronic administration of various drugs of abuse such as ethanol, opiates, and psychostimulants results in withdrawal syndromes largely unique to each drug class. However, one symptom that appears common to these withdrawal syndromes in humans is a negative affective/motivational state. Prior work in rodents has shown that elevations in intracranial self-stimulation (ICSS) reward thresholds provide a quantitative index that serves as a model for the negative affective state during withdrawal from psychostimulants and opiates. The current study sought to determine whether ICSS threshold elevations also accompany abstinence from chronic ethanol exposure sufficient to induce physical dependence. Rats prepared with stimulating electrodes in the lateral hypothalamus were trained in a discrete-trial current-intensity ICSS threshold procedure; subsequently they were subjected to chronic ethanol administration in ethanol vapor chambers (average blood alcohol level of 197 mg/dl). A time-dependent elevation in ICSS thresholds was observed following removal from the ethanol, but not the control, chambers. Thresholds were significantly elevated for 48 hr after cessation of ethanol exposure, with peak elevations observed at 6-8 hr. Blood alcohol levels were directly correlated with the magnitude of peak threshold elevation. Ratings of traditional overt signs of withdrawal showed a similar time course of expression and resolution. The results suggest that decreased function of reward systems (elevations in reward thresholds) is a common element of withdrawal from chronic administration of several diverse classes of abused drugs.
Similar articles
- Adolescent intermittent ethanol exposure diminishes anhedonia during ethanol withdrawal in adulthood.
Boutros N, Semenova S, Markou A. Boutros N, et al. Eur Neuropsychopharmacol. 2014 Jun;24(6):856-64. doi: 10.1016/j.euroneuro.2014.01.022. Epub 2014 Feb 4. Eur Neuropsychopharmacol. 2014. PMID: 24560005 Free PMC article. - Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats.
Schulteis G, Liu J. Schulteis G, et al. Alcohol. 2006 May;39(1):21-8. doi: 10.1016/j.alcohol.2006.06.008. Epub 2006 Jul 28. Alcohol. 2006. PMID: 16938626 Free PMC article. - Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
Lin D, Koob GF, Markou A. Lin D, et al. Psychopharmacology (Berl). 1999 Aug;145(3):283-94. doi: 10.1007/s002130051060. Psychopharmacology (Berl). 1999. PMID: 10494577 - Alcoholism: allostasis and beyond.
Koob GF. Koob GF. Alcohol Clin Exp Res. 2003 Feb;27(2):232-43. doi: 10.1097/01.ALC.0000057122.36127.C2. Alcohol Clin Exp Res. 2003. PMID: 12605072 Review. - Neuropharmacology of cocaine and ethanol dependence.
Koob GF, Weiss F. Koob GF, et al. Recent Dev Alcohol. 1992;10:201-33. doi: 10.1007/978-1-4899-1648-8_11. Recent Dev Alcohol. 1992. PMID: 1350359 Review.
Cited by
- Addiction as a stress surfeit disorder.
Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, Schmeichel B, Vendruscolo LF, Wade CL, Whitfield TW Jr, George O. Koob GF, et al. Neuropharmacology. 2014 Jan;76 Pt B(0 0):370-82. doi: 10.1016/j.neuropharm.2013.05.024. Epub 2013 Jun 6. Neuropharmacology. 2014. PMID: 23747571 Free PMC article. Review. - Modeling relapse in animals.
Martin-Fardon R, Weiss F. Martin-Fardon R, et al. Curr Top Behav Neurosci. 2013;13:403-32. doi: 10.1007/7854_2012_202. Curr Top Behav Neurosci. 2013. PMID: 22389178 Free PMC article. Review. - Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.
Walker BM, Valdez GR, McLaughlin JP, Bakalkin G. Walker BM, et al. Alcohol. 2012 Jun;46(4):359-70. doi: 10.1016/j.alcohol.2011.10.006. Epub 2012 Mar 27. Alcohol. 2012. PMID: 22459870 Free PMC article. Review. - Animal models and treatments for addiction and depression co-morbidity.
Paterson NE, Markou A. Paterson NE, et al. Neurotox Res. 2007 Jan;11(1):1-32. doi: 10.1007/BF03033479. Neurotox Res. 2007. PMID: 17449445 Review. - Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
Bruijnzeel AW, Prado M, Isaac S. Bruijnzeel AW, et al. Biol Psychiatry. 2009 Jul 15;66(2):110-7. doi: 10.1016/j.biopsych.2009.01.010. Epub 2009 Feb 12. Biol Psychiatry. 2009. PMID: 19217073 Free PMC article.
References
- Psychol Rev. 1974 Mar;81(2):119-45 - PubMed
- Science. 1971 Apr 16;172(3980):288-90 - PubMed
- Psychopharmacologia. 1975 Sep 17;43(3):245-54 - PubMed
- Psychopharmacologia. 1976;46(1):19-25 - PubMed
- Psychopharmacology (Berl). 1976 Nov 10;50(2):107-12 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical